Morphine and antibodies to mu-opiate receptors in ultralow doses: effect on oxygen consumption

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• Morphine, an opioid analgesic, affects physiological processes like oxygen consumption.
• The biphasic effect of drugs, where low doses have opposite effects to high doses, is a known phenomenon.
• Opioid receptors, particularly mu-opiate receptors, are crucial in mediating the effects of morphine.

Purpose of the Study:

• To investigate the effect of ultralow doses of morphine and antibodies to mu-opiate receptors on oxygen consumption in rats.
• To explore the potential of potentiation technology in modulating morphine's effects.
• To understand the role of mu-opiate receptors in morphine-induced physiological changes and potential dependence.

Main Methods:

• Rats were administered intraperitoneal injections of morphine (5 mg/kg).
• Some rats received peroral administration of potentiated morphine or potentiated antibodies to mu-opiate receptors.
• Oxygen consumption levels were measured to assess the physiological response.

Main Results:

• Morphine administration at 5 mg/kg increased oxygen consumption.
• Potentiated morphine and potentiated antibodies to mu-opiate receptors significantly reduced morphine-induced oxygen consumption.
• Potentiated morphine normalized oxygen consumption to levels seen in intact animals.

Conclusions:

• Morphine exhibits a biphasic effect, with ultralow doses modulating its action at higher concentrations.
• Potentiated ultralow doses of morphine and antibodies to mu-opiate receptors demonstrate a normalizing effect on oxygen consumption.
• The involvement of mu-opiate receptors in modulating morphine's effects suggests their role in the development of opioid dependence.